Summary
- Dexcom has acquired TypeZero Technologies for an undisclosed sum.
- TypeZero has developed a diabetes patient system and algorithm that helps improve insulin delivery and optimization.
- DXCM acquired TypeZero to bolster its launch of an automated insulin delivery [AID] in 2019 incorporating TypeZero's diabetes management algorithm.
- Members of our private investing community, IPO Edge, get our best ideas and insights. Get started today >>
Quick Take
Dexcom (DXCM) announced it has acquired TypeZero Technologies for an undisclosed amount.
TypeZero Technologies provides diabetes management software for patients and clinicians.
DXCM plans to launch an automated insulin delivery system based on TypeZero’s inControl algorithm in 2019.
